363 related articles for article (PubMed ID: 15316148)
1. The role of the FcepsilonRI beta-chain in allergic diseases.
Kraft S; Rana S; Jouvin MH; Kinet JP
Int Arch Allergy Immunol; 2004 Sep; 135(1):62-72. PubMed ID: 15316148
[TBL] [Abstract][Full Text] [Related]
2. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in FcepsilonRI beta chain do not affect IgE-mediated mast cell activation.
Furumoto Y; Hiraoka S; Kawamoto K; Masaki S; Kitamura T; Okumura K; Ra C
Biochem Biophys Res Commun; 2000 Jul; 273(2):765-71. PubMed ID: 10873678
[TBL] [Abstract][Full Text] [Related]
4. IgE and Fc{epsilon}RI regulation.
Macglashan D
Ann N Y Acad Sci; 2005 Jun; 1050():73-88. PubMed ID: 16014522
[TBL] [Abstract][Full Text] [Related]
5. Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE.
Nunomura S; Gon Y; Yoshimaru T; Suzuki Y; Nishimoto H; Kawakami T; Ra C
Int Immunol; 2005 Jun; 17(6):685-94. PubMed ID: 15944196
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Trafficking and Signaling of the High Affinity IgE Receptor by FcεRIβ and the Potential Impact of FcεRIβ Splicing in Allergic Inflammation.
Arthur GK; Cruse G
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054974
[TBL] [Abstract][Full Text] [Related]
7. IgE signaling suppresses FcepsilonRIbeta expression.
Brenzovich J; Macey M; Fernando J; Chong HJ; Barnstein B; Mirmonsef P; Morales JK; Kimura A; Cruz TD; Ryan JJ
J Leukoc Biol; 2009 Dec; 86(6):1351-8. PubMed ID: 19741159
[TBL] [Abstract][Full Text] [Related]
8. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
[TBL] [Abstract][Full Text] [Related]
9. IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.
Zellweger F; Buschor P; Hobi G; Brigger D; Dahinden CA; Villiger PM; Eggel A
Cell Death Dis; 2018 May; 9(5):510. PubMed ID: 29724998
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the Fc epsilon RI beta promoter region affecting transcription activity: a possible promoter-dependent mechanism for association between Fc epsilon RI beta and atopy.
Nishiyama C; Akizawa Y; Nishiyama M; Tokura T; Kawada H; Mitsuishi K; Hasegawa M; Ito T; Nakano N; Okamoto A; Takagi A; Yagita H; Okumura K; Ogawa H
J Immunol; 2004 Nov; 173(10):6458-64. PubMed ID: 15528387
[TBL] [Abstract][Full Text] [Related]
11. Exon Skipping of FcεRIβ for Allergic Diseases.
Arthur GK; Cruse G
Methods Mol Biol; 2018; 1828():503-518. PubMed ID: 30171564
[TBL] [Abstract][Full Text] [Related]
12. Houttuynia cordata water extract suppresses anaphylactic reaction and IgE-mediated allergic response by inhibiting multiple steps of FcepsilonRI signaling in mast cells.
Han EH; Park JH; Kim JY; Jeong HG
Food Chem Toxicol; 2009 Jul; 47(7):1659-66. PubMed ID: 19394399
[TBL] [Abstract][Full Text] [Related]
13. Are basophil histamine release and high affinity IgE receptor expression involved in asymptomatic skin sensitization?
Jensen BM; Assing K; Hummelshoj L; Glue C; Skov PS; Poulsen LK
Allergy; 2006 Mar; 61(3):303-10. PubMed ID: 16436138
[TBL] [Abstract][Full Text] [Related]
14. SLAP Is a Negative Regulator of FcεRI Receptor-Mediated Signaling and Allergic Response.
Sharma N; Ponce M; Kaul S; Pan Z; Berry DM; Eiwegger T; McGlade CJ
Front Immunol; 2019; 10():1020. PubMed ID: 31156621
[TBL] [Abstract][Full Text] [Related]
15. The interaction between Lyn and FcεRIβ is indispensable for FcεRI-mediated human mast cell activation.
Okayama Y; Kashiwakura JI; Matsuda A; Sasaki-Sakamoto T; Nunomura S; Yokoi N; Ebihara N; Kuroda K; Ohmori K; Saito H; Ra C
Allergy; 2012 Oct; 67(10):1241-9. PubMed ID: 22845063
[TBL] [Abstract][Full Text] [Related]
16. The immunoglobulin E-Toll-like receptor network.
Novak N; Bieber T; Peng WM
Int Arch Allergy Immunol; 2010; 151(1):1-7. PubMed ID: 19672091
[TBL] [Abstract][Full Text] [Related]
17. The Transcription Factor Ehf Is Involved in TGF-β-Induced Suppression of FcεRI and c-Kit Expression and FcεRI-Mediated Activation in Mast Cells.
Yamazaki S; Nakano N; Honjo A; Hara M; Maeda K; Nishiyama C; Kitaura J; Ohtsuka Y; Okumura K; Ogawa H; Shimizu T
J Immunol; 2015 Oct; 195(7):3427-35. PubMed ID: 26297757
[TBL] [Abstract][Full Text] [Related]
18. Identification of redundancy between human FcεRIβ and MS4A6A proteins points toward additional complex mechanisms for FcεRI trafficking and signaling.
Bitting K; Hedgespeth B; Ehrhardt-Humbert LC; Arthur GK; Schubert AG; Bradding P; Tilley SL; Cruse G
Allergy; 2023 May; 78(5):1204-1217. PubMed ID: 36424895
[TBL] [Abstract][Full Text] [Related]
19. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
[TBL] [Abstract][Full Text] [Related]
20. FcεRI-induced mast cell cytokine production critically involves an aspartic acid residue (D234) in the C-terminal intracellular domain of the FcεRIβ chain.
Terada T; Nunomura S; Shimokawa T; Murayama K; Era S; Kondo N; Ra C
Biochem Biophys Res Commun; 2011 Jul; 410(4):744-8. PubMed ID: 21683687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
